Clinical Trial Update: Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dronabinol as an adjunctive treatment for agitation in Alzheimer's disease has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Dronabinol (dronabinol)

Snippet

Sponsor: Johns Hopkins University | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-05-09